NPM1 and acute myeloid leukemia: Recently, NPM1 mutations have also been found to bear favorable outcomes even when occurring in therapy-related AML [13] while co-occurring chromosomal abnormalities have been associated with poorer outcomes [14] highlighting context-sensitive genetic heterogeneity in NPM1-mutated AML.